Heart Failure Optimization at Home to Improve Outcomes (Hozho): A Pragmatic in Navajo Nation

Heart failure causes significant morbidity and mortality, particularly in Navajo Nation. There are well-established evidence of improved mortality and lower heart failure hospitalizations with certain pharmacotherapies for heart failure with reduced ejection fraction (HFrEF). However, these medications are underutilized nationally, including in the Indian Health Service which is one important driver of poor heart failure outcomes. Therefore, as part of an EHR-based pragmatic clinic trial, we are implementing and testing a model that identifies American Indian HFrEF patients receiving care at one large Indian Health Service Site who meet clinical criteria for, but are not on appropriate therapy, and implement a model in which our study team will get patients on appropriate therapy while also supporting primary care providers with cardiology telementorship. We will evaluate the impact of this model to improve uptake of GDMT among HFrEF patients.